Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy

The epidermal growth factor receptor (EGFR) is a transmembrane tyrosine kinase receptor involved in the proliferation and survival of cancer cells. EGFR is the first molecular target against which monoclonal antibodies (mAb) have been developed for cancer therapy. Here we review the mechanisms under...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Martinelli, E, De Palma, R, Orditura, M, De Vita, F, Ciardiello, F
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2009
Teme:
Review Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2759052/
https://ncbi.nlm.nih.gov/pubmed/19737224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2009.03992.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items